Drug intelligence / Profile preview

CK21 fat emulsion injection

Development stage: Unknown
Lead developer: Xinkai Medicine and Chemical Intermediates
Modality: Small Molecules
Administration: Intravenous

Overview

CK21 fat emulsion injection is an investigational antineoplastic agent developed by Xinkai Pharmaceutical Chemical Intermediates (Shanghai) Co., Ltd. (also known as Cinkate). It is formulated as a fat emulsion for intravenous administration, a delivery system often utilized to improve the solubility and pharmacokinetic profile of lipophilic compounds. The drug is currently being evaluated in Phase Ia clinical trials for the treatment of advanced malignant solid tumors, with a particular focus on pancreatic cancer. While the specific active pharmaceutical ingredient (API) is not publicly disclosed in standard registries, the development program aims to assess the safety, tolerability, and preliminary antitumor activity of this novel formulation in adult patients with refractory malignancies.

Other names: CK21脂肪乳注射液

Targets

ERCC3 (General transcription and DNA repair factor IIH helicase subunit XPB)BCL-2 (BCL-2 family)

Beyond the preview

Go deeper on CK21 fat emulsion injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CK21 fat emulsion injection.

Explore the full profile